Table 1.
GBC | XGC | CC | HC | OR (95% CI) among different groups | AOR (95% CI) | P-value | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
No. | Positive No. (%) | No. | Positive No. (%) | No. | Positive No. (%) | No. | Positive No. (%) | |||||
Female | 74 | 12 (16) | 11 | 2 (18) | 125 | 30 (24) | 9 | 0 | GBC vs. HC GBC vs. CC GBC vs. XGC XGC vs. HC XGC vs. CC |
3.8 (0.2-69.7) 0.6 (0.3-1.3) 0.9 (0.2-4.5) 5.0 (0.2-118.7) 0.7 (0.1-3.4) |
0.24 | |
Male | 26 | 10 (38) | 13 | 5 (38) | 75 | 21 (28) | 191 | 5 (3) | GBC vs. HC GBC vs. CC GBC vs. XGC XGC vs. HC XGC vs. CC |
23.3 (7.1-76.4) 1.6 (0.6-4.1) 1.0 (0.3-4.0) 23.3 (5.6-96.9) 1.6 (0.5-5.5) |
< 0.001* | |
Total | 100 | 22 (22) | 24 | 7 (29) | 200 | 51 (26) | 200 | 5 (3) | GBC vs. HC GBC vs. CC GBC vs. XGC XGC vs. HC XGC vs. CC |
11.0 (4.0-30.1) 0.8 (0.5-1.5) 0.7 (0.3-1.9) 16.1 (4.6-56.1) 1.2 (0.5-3.1) |
0.0 (0.0-0.0) 0.6 (0.3-1.0) 1.0 (0.9-1.0) 0.0 (0.0-0.1) 1.0 (0.9-1.0) |
< 0.001* |
CC, Chronic cholecystitis; GBC, Gall bladder cancer; HC, Healthy controls; XGC, Xanthogranulomatous cholecystitis